Avalon GloboCare Files 8-K

Ticker: ALBT · Form: 8-K · Filed: Aug 14, 2024 · CIK: 1630212

Sentiment: neutral

Topics: 8-K, disclosure, financial-statements

TL;DR

Avalon GloboCare filed an 8-K, likely with financial updates. Keep an eye out.

AI Summary

Avalon GloboCare Corp. filed an 8-K on August 14, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or details about the nature of the disclosure.

Why It Matters

This filing indicates Avalon GloboCare Corp. is making a regulatory disclosure and submitting financial documents, which could contain important updates for investors.

Risk Assessment

Risk Level: medium — The filing is a standard 8-K for disclosures and financial statements, but the lack of specific details within the provided text warrants a medium risk assessment until the content is reviewed.

Key Players & Entities

FAQ

What specific information is being disclosed under Regulation FD?

The provided text of the 8-K filing does not specify the details of the Regulation FD disclosure.

What financial statements are included in this filing?

The filing indicates that Financial Statements and Exhibits are being submitted, but the specific statements are not detailed in the provided text.

When was Avalon GloboCare Corp. incorporated?

Avalon GloboCare Corp. was incorporated in Delaware.

What is the principal executive office address for Avalon GloboCare Corp.?

The principal executive offices are located at 4400 Route 9 South, Suite 3100, Freehold, NJ 07728.

What is the Commission File Number for Avalon GloboCare Corp.?

The Commission File Number for Avalon GloboCare Corp. is 001-38728.

Filing Stats: 564 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-08-14 08:29:00

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AVALON GLOBOCARE CORP. Dated: August 14, 2024 By: /s/ Luisa Ingargiola Name: Luisa Ingargiola Title: Chief Financial Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing